Differential modulation of nitric oxide synthases in aging: Therapeutic opportunities

Frontiers in Physiology

Volumn 3 JUN, Issue , 2012, Pages

  Cau, Stefany B A ^a   Carneiro, Fernando S ^a   Tostes, Rita C ^a  

^a UNIVERSITY OF SÃO PAULO   (Brazil)

Author keywords

Aging; Endothelial dysfunction; Folic acid; Nitric oxide; Nitric oxide synthases; Resveratrol; Statin; Uncoupled eNOS

Indexed keywords

EID: 84866346582     PISSN: None     EISSN: 1664042X     Source Type: Journal    
DOI: 10.3389/fphys.2012.00218     Document Type: Review

References (128)

1. Alp, N. J., Mussa, S., Khoo, J., Cai, S., Guzik, T., Jefferson, A., Goh, N., Rockett, K. A., and Channon, K. M. (2003). Tetrahydrobiopterin-dependent preservation of nitric oxide-mediated endothelial function in diabetes by targeted transgenic GTP-cyclohydrolase I over-expression. J. Clin. Invest. 112, 725-735.
2. Antoniades, C., Bakogiannis, C., Leeson, P., Guzik, T. J., Zhang, M. H., Tousoulis, D., Antonopoulos, A. S., Demosthenous, M., Marinou, K., Hale, A., Paschalis, A., Psarros, C., Triantafyllou, C., Bendall, J., Casadei, B., Stefanadis, C., and Channon, K. M. (2011). Rapid, direct effects of statin treatment on arterial redox state and nitric oxide bioavailability in human atherosclerosis via tetrahydrobiopterin-mediated endothelial nitric oxide synthase coupling. Circulation 124, 335-345.
3. Antoniades, C., Shirodaria, C., Warrick, N., Cai, S., de Bono, J., Lee, J., Leeson, P., Neubauer, S., Ratnatunga, C., Pillai, R., Refsum, H., and Channon, K. M. (2006). 5-Methyltetrahydrofolate rapidly improves endothelial function and decreases superoxide production in human vessels: effects on vascular tetrahydrobiopterin availability and endothelial nitric oxide synthase coupling. Circulation 114, 1193-1201.
4. Aoki, C., Nakano, A., Tanaka, S., Yanagi, K., Ohta, S., Jojima, T., Kasai, K., Takekawa, H., Hirata, K., and Hattori, Y. (2012). Fluvastatin upregulates endothelial nitric oxide synthase activity via enhancement of its phosphorylation and expression and via an increase in tetrahydrobiopterin in vascular endothelial cells. Int. J. Cardiol. 156, 55-61.
5. Baigent, C., Keech, A., Kearney, P. M., Blackwell, L., Buck, G., Pollicino, C., Kirby, A., Sourjina, T., Peto, R., Collins, R., and Simes, R. (2005). Efficacy and safety of cholesterol-lowering treatment: prospective meta-analysis of data from 90, 056 participants in 14 randomised trials of statins. Lancet 366, 1267-1278.
6. Barger, J. L., Kayo, T., Vann, J. M., Arias, E. B., Wang, J., Hacker, T. A., Wang, Y., Raederstorff, D., Morrow, J. D., Leeuwenburgh, C., Allison, D. B., Saupe, K. W., Cartee, G. D., Weindruch, R., and Prolla, T. A. (2008). A low dose of dietary resveratrol partially mimics caloric restriction and retards aging parameters in mice. PLoS ONE 3, e2264. doi:10.1371/journal.pone.0002264
7. Baur, J. A., Pearson, K. J., Price, N. L., Jamieson, H. A., Lerin, C., Kalra, A., Prabhu, V. V., Allard, J. S., Lopez-Lluch, G., Lewis, K., Pistell, P. J., Poosala, S., Becker, K. G., Boss, O., Gwinn, D., Wang, M., Ramaswamy, S., Fishbein, K. W., Spencer, R. G., Lakatta, E. G., Le Couteur, D., Shaw, R. J., Navas, P., Puigserver, P., Ingram, D. K., de Cabo, R., and Sinclair, D. A. (2006). Resveratrol improves health and survival of mice on a high-calorie diet. Nature 444, 337-342.
8. Bhatt, S. R., Lokhandwala, M. F., and Banday, A. A. (2011). Resveratrol prevents endothelial nitric oxide synthase uncoupling and attenuates development of hypertension in spontaneously hypertensive rats. Eur. J. Pharmacol. 667, 258-264.
9. Blackwell, K. A., Sorenson, J. P., Richardson, D. M., Smith, L. A., Suda, O., Nath, K., and Katusic, Z. S. (2004). Mechanisms of aging-induced impairment of endothelium-dependent relaxation: role of tetrahydrobiopterin. Am. J. Physiol. Heart Circ. Physiol. 287, H2448-H2453.
10. Bolli, R. (2001). Cardioprotective function of inducible nitric oxide synthase and role of nitric oxide in myocardial ischemia and preconditioning: an overview of a decade of research. J. Mol. Cell. Cardiol. 33, 1897-1918.
11. Brasnyo, P., Molnar, G. A., Mohas, M., Marko, L., Laczy, B., Cseh, J., Mikolas, E., Szijarto, I. A., Merei, A., Halmai, R., Meszaros, L. G., Sumegi, B., andWittmann, I. (2011). Resveratrol improves insulin sensitivity, reduces oxidative stress and activates the Akt pathway in type 2 diabetic patients. Br. J. Nutr. 106, 383-389.
12. Briones, A. M., Montoya, N., Giraldo, J., and Vila, E. (2005). Ageing affects nitric oxide synthase, cyclooxyge-nase and oxidative stress enzymes expression differently in mesenteric resistance arteries. Auton. Autacoid Pharmacol. 25, 155-162.
13. Cau, S. B., and Tostes, R. C. (2012). mTOR Inhibition: a promise for a young heart. Front. Physiol. 3:31. doi:10.3389/fphys.2012.00031
14. Cernadas, M. R., Sanchez de Miguel, L., Garcia-Duran, M., Gonzalez-Fernandez, F., Millas, I., Monton, M., Rodrigo, J., Rico, L., Fernandez, P., de Frutos, T., Rodriguez-Feo, J. A., Guerra, J., Caramelo, C., Casado, S., and Farre, L. (1998). Expression of constitutive and inducible nitric oxide synthases in the vascular wall of young and aging rats. Circ. Res. 83, 279-286.
15. Challah, M., Nadaud, S., Philippe, M., Battle, T., Soubrier, F., Corman, B., and Michel, J. B. (1997). Circulating and cellular markers of endothelial dysfunction with aging in rats. Am. J. Physiol. 273(Pt 2), H1941-H1948.
16. Chantler, P. D., Nussbacher, A., Gerstenblith, G., Schulman, S. P., Becker, L. C., Ferrucci, L., Fleg, J. L., Lakatta, E. G., and Najjar, S. S. (2011). Abnormalities in arterial-ventricular coupling in older healthy persons are attenuated by sodium nitroprusside. Am. J. Physiol. Heart Circ. Physiol. 300, H1914-H1922.
17. Chou, T. C., Yen, M. H., Li, C. Y., and Ding, Y A. (1998). Alterations of nitric oxide synthase expression with aging and Hypertension in rats. Hypertension 31, 643-648.
18. Cosby, K., Partovi, K. S., Crawford, J. H., Patel, R. P., Reiter, C. D., Martyr, S., Yang, B. K., Waclawiw, M. A., Zalos, G., Xu, X., Huang, K. T., Shields, H., Kim-Shapiro, D. B., Schechter, A. N., Cannon, R. O. III., and Gladwin, M. T. (2003). Nitrite reduction to nitric oxide by deoxyhemoglobin vaso dilates the human circulation. Nat. Med. 9, 1498-1505.
19. Crandall, J. P., Oram, V., Trandafirescu, G., Reid, M., Kishore, P., Hawkins, M., Cohen, H. W., and Barzilai, N. (2012). Pilot study of resveratrol in older adults with impaired glucose tolerance. J. Gerontol. A Biol. Sci. Med. Sci. 67A, 1-6.
20. Csiszar, A., Ungvari, Z., Edwards, J. G., Kaminski, P., Wolin, M. S., Koller, A., and Kaley, G. (2002). Aging-induced phenotypic changes and oxidative stress impair coronary arteriolar function. Circ. Res. 90, 1159-1166.
21. de Sotomayor, M. A., Perez-Guerrero, C., Herrrera, M. D., Jimenez, L., Marin, R., Marhuenda, E., and Andriantsitohaina, R. (2005). Improvement of age-related endothelial dysfunction by sim-vastatin: effect on NO and COX pathways. Br. J. Pharmacol. 146, 1130-1138.
22. Dejam, A., Hunter, C. J., Schechter, A. N., and Gladwin, M. T. (2004). Emerging role of nitrite in human biology. Blood Cells Mol. Dis. 32, 423-429.
23. Delp, M. D., Behnke, B. J., Spier, S. A., Wu, G., and Muller-Delp, J. M. (2008). Ageing diminishes endothelium-dependent vasodilatation and tetrahydrobiopterin content in rat skeletal muscle arterioles. J. Physiol. (Lond.) 586, 1161-1168.
24. Denniss, S. G., Levy, A. S., and Rush, J. W. (2011). Effects of glutathione-depleting drug buthionine sulfoximine and aging on activity of endothelium-derived relaxing and contracting factors in carotid artery of sprague-dawley rats. J. Cardiovasc. Pharmacol. 58, 272-283.
25. Dere, E., De Souza Silva, M. A., Topic, B., Fiorillo, C., Li, J. S., Sadile, A. G., Frisch, C., and Huston, J. P. (2002). Aged endothelial nitric oxide synthase knockout mice exhibit higher mortality concomitant with impaired open-field habituation and alterations in forebrain neurotransmitter levels. Genes Brain Behav. 1, 204-213.
26. Donato, A. J., Pierce, G. L., Lesniewski, L. A., and Seals, D. R. (2009). Role of NFkappaB in age-related vascular endothelial dysfunction in humans. Aging (Albany NY) 1, 678-680.
27. Dudzinski, D. M., and Michel, T. (2007). Life history of eNOS: partners and pathways. Cardiovasc. Res. 75, 247-260.
28. Ferrer, M., and Balfagon, G. (2001). Aging alters neuronal nitric oxide release from rat mesenteric arteries: role of presynaptic beta-adrenoceptors. Clin. Sci. 101, 321-328.
29. Ferrer, M., Sanchez, M., Minoves, N., Salaices, M., and Balfagon, G. (2003). Aging increases neuronal nitric oxide release and superoxide anion generation in mesenteric arteries from spontaneously hypertensive rats. J. Vasc. Res. 40, 509-519.
30. Fiorucci, S., Antonelli, E., Burgaud, J. L., and Morelli, A. (2001). Nitric oxide-releasing NSAIDs: a review of their current status. Drug Saf. 24, 801-811.
31. Fleenor, B. S., Seals, D. R., Zigler, M. L., and Sindler, A. L. (2011). Superoxide-lowering therapy with TEMPOL reverses arterial dysfunction with aging in mice. Aging Cell 11, 269-276.
32. Foody, J. M., Rathore, S. S., Galusha, D., Masoudi, F. A., Havranek, E. P., Radford, M. J., and Krumholz, H. M. (2006). Hydroxymethylglutaryl-CoA reductase inhibitors in older persons with acute myocardial infarction: evidence for an age-statin interaction. J. Am. Geriatr. Soc. 54, 421-430.
33. Forstermann, U., and Li, H. (2011). Therapeutic effect of enhancing endothelial nitric oxide synthase (eNOS) expression and preventing eNOS uncoupling. Br. J. Pharmacol. 164, 213-223.
34. Fulop, N., Feng, W., Xing, D., He, K., Not, L. G., Brocks, C. A., Marchase, R. B., Miller, A. P., and Chatham, J. C. (2008). Aging leads to increased levels of protein O-linked N-acetylglucosamine in heart, aorta, brain and skeletal muscle in Brown-Norway rats. Biogerontology 9, 139-151.
35. Gao, L., Siu, K. L., Chalupsky, K., Nguyen, A., Chen, P., Weintraub, N. L., Galis, Z., and Cai, H. (2012). Role of uncoupled endothelial nitric oxide synthase in abdominal aortic aneurysm formation: treatment with folic acid. Hypertension 59, 158-166.
36. Gates, P. E., Boucher, M. L., Silver, A. E., Monahan, K. D., and Seals, D. R. (2007). Impaired flow-mediated dilation with age is not explained by L-arginine bioavailability or endothelial asymmetric dimethylarginine protein expression. J. Appl. Physiol. 102, 63-71.
37. Gerhard, M., Roddy, M. A., Creager, S. J., and Creager, M. A. (1996). Aging progressively impairs endothelium-dependent vasodilation in forearm resistance vessels of humans. Hypertension 27, 849-853.
38. Glenn, C. L., Wang, W. Y., and Morris, B. J. (1999). Different frequencies of inducible nitric oxide synthase genotypes in older hypertensives. Hypertension 33, 927-932.
39. Goettsch, W., Lattmann, T., Amann, K., Szibor, M., Morawietz, H., Munter, K., Muller, S. P., Shaw, S., and Barton, M. (2001). Increased expression of endothelin-1 and inducible nitric oxide synthase isoform II in aging arteries in vivo: implications for atherosclerosis. Biochem. Biophys. Res. Commun. 280, 908-913.
40. Gransbo, K., Melander, O., Wallentin, L., Lindback, J., Stenestrand, U., Carlsson, J., and Nilsson, J. (2010). Cardiovascular and cancer mortality in very elderly post-myocardial infarction patients receiving statin treatment. J. Am. Coll. Cardiol. 55, 1362-1369.
41. Hamilton, C. A., Brosnan, M. J., McIntyre, M., Graham, D., and Dominiczak, A. F. (2001). Superoxide excess in hypertension and aging: a common cause of endothelial dysfunction. Hypertension 37(Pt 2), 529-534.
42. Hattori, Y., Nakanishi, N., Akimoto, K., Yoshida, M., and Kasai, K. (2003). HMG-CoA reductase inhibitor increases GTP cyclohydrolase I mRNA and tetrahydrobiopterin in vascular endothelial cells. Arterioscler. Thromb. Vasc. Biol. 23, 176-182.
43. Hecker, M., Cattaruzza, M., and Wagner, A. H. (1999). Regulation of inducible nitric oxide synthase gene expression in vascular smooth muscle cells. Gen. Pharmacol. 32, 9-16.
44. Herrera, M. D., Mingorance, C., Rodriguez-Rodriguez, R., and Alvarez de Sotomayor, M. (2010). Endothelial dysfunction and aging: an update. Ageing Res. Rev. 9, 142-152.
45. Higashi, Y., Sasaki, S., Nakagawa, K., Kimura, M., Noma, K., Hara, K., Jitsuiki, D., Goto, C., Oshima, T., Chayama, K., and Yoshizumi, M. (2006). Tetrahydrobiopterin improves aging-related impairment of endothelium-dependent vaso dilation through increase in nitric oxide production. Atherosclerosis 186, 390-395.
46. Kapil, V., Milsom, A. B., Okorie, M., Maleki-Toyserkani, S., Akram, F., Rehman, F., Arghandawi, S., Pearl, V., Benjamin, N., Loukogeorgakis, S., MacAllister, R., Hobbs, A. J., Webb, A. J., and Ahluwalia, A. (2010). Inorganic nitrate supplementation lowers blood pressure in humans: role for nitrite-derived NO. Hypertension 56, 274-281.
47. Kar, P., Laight, D., Rooprai, H. K., Shaw, K. M., and Cummings, M. (2009). Effects of grape seed extract in Type 2 diabetic subjects at high cardiovascular risk: a double blind randomized placebo controlled trial examining metabolic markers, vascular tone, inflammation, oxidative stress and insulin sensitivity. Diabet. Med. 26, 526-531.
48. Kawano, H., Yasue, H., Kitagawa, A., Hirai, N., Yoshida, T., Soejima, H., Miyamoto, S., Nakano, M., and Ogawa, H. (2003). Dehy-droepiandrosterone supplementation improves endothelial function and insulin sensitivity in men. J. Clin. Endocrinol. Metab. 88, 3190-3195.
49. Kim, J. H., Bugaj, L. J., Oh, Y. J., Bivalacqua, T. J., Ryoo, S., Soucy, K. G., Santhanam, L., Webb, A., Camara, A., Sikka, G., Nyhan, D., Shoukas, A. A., Ilies, M., Christianson, D. W., Champion, H. C., and Berkowitz, D. E. (2009). Arginase inhibition restores NOS coupling and reverses endothelial dysfunction and vascular stiffness in old rats. J. Appl. Physiol. 107, 1249-1257.
50. Kurt, R., Yilmaz, Y., Ermis, F., Kalayoglu Besisik, S., Polat, N., Elitok, A., Oflaz, H., and Karan, M. A. (2010). Folic Acid and vitamin B12 supplementation improves coronary flow reserve in elderly subjects with vitamin B12 deficiency. Arch. Med. Res. 41, 369-372.
51. Labinskyy, N., Csiszar, A., Veress, G., Stef, G., Pacher, P., Oroszi, G., Wu, J., and Ungvari, Z. (2006). Vascular dysfunction in aging: potential effects of resveratrol, an anti-inflammatory phytoestrogen. Curr. Med. Chem. 13, 989-996.
52. Lakatta, E. G., and Levy, D. (2003). Arterial and cardiac aging: major shareholders in cardiovascular disease enterprises: Part I: aging arteries: a "set up" for vascular disease. Circulation 107, 139-146.
53. Lamberts, S. W., van den Beld, A. W., and van der Lely, A. J. (1997). The endocrinology of aging. Science 278, 419-424.
54. Larsen, F. J., Ekblom, B., Sahlin, K., Lundberg, J. O., and Weitzberg, E. (2006). Effects of dietary nitrate on blood pressure in healthy volunteers. N. Engl. J. Med. 355, 2792-2793.
55. Laufs, U., La Fata, V., Plutzky, J., and Liao, J. K. (1998). Upregulation of endothelial nitric oxide synthase by HMG CoA reductase inhibitors. Circulation 97, 1129-1135.
56. Laufs, U., and Liao, J. K. (1998). Post-transcriptional regulation of endothelial nitric oxide synthase mRNA stability by Rho GTPase. J. Biol. Chem. 273, 24266-24271.
57. LeBlanc, A. J., Reyes, R., Kang, L. S., Dailey, R. A., Stallone, J. N., Moningka, N. C., and Muller-Delp, J. M. (2009). Estrogen replacement restores flow-induced vasodilation in coronary arterioles of aged and ovariectomized rats. Am. J. Physiol. Regul. Integr. Comp. Physiol. 297, R1713-R1723.
58. Lekakis, J., Rallidis, L. S., Andreadou, I., Vamvakou, G., Kazantzoglou, G., Magiatis, P., Skaltsounis, A. L., and Kremastinos, D. T. (2005). Polyphenolic compounds from red grapes acutely improve endothelial function in patients with coronary heart disease. Eur. J. Cardiovasc. Prev. Rehabil. 12, 596-600.
59. Lekontseva, O., Chakrabarti, S., Jiang, Y., Cheung, C. C., and Davidge, S. T. (2011). Role of neuronal nitricoxide synthase in estrogen-induced relaxation in rat resistance arteries. J. Pharmacol. Exp. Ther. 339, 367-375.
60. Li, H., Xia, N., and Forstermann, U. (2012). Cardiovascular effects and molecular targets of resveratrol. Nitric Oxide 26, 102-110.
61. Liang, M., Ekblad, E., Lydrup, M. L., and Nilsson, B. O. (2003). Combined lack of estrogen receptors alpha and beta affects vascular iNOS protein expression. Cell Tissue Res. 313, 63-70.
62. Lima, V. V., Rigsby, C. S., Hardy, D. M., Webb, R. C., and Tostes, R. C. (2009). O-GlcNAcylation: a novel post-translational mechanism to alter vascular cellular signaling in health and disease: focus on hypertension. J. Am. Soc. Hypertens. 3, 374-387.
63. Lund, D. D., Chu, Y., Miller, J. D., and Heistad, D. D. (2009). Protective effect of extracellular superoxide dismutase on endothelial function during aging. Am. J. Physiol. Heart Circ. Physiol. 296, H1920-H1925.
64. Matz, R. L., de Sotomayor, M. A., Schott, C., Stoclet, J. C., and Andriantsitohaina, R. (2000). Vascular bed heterogeneity in age-related endothelial dysfunction with respect to NO and eicosanoids. Br. J. Pharmacol. 131, 303-311.
65. Melikian, N., Seddon, M. D., Casadei, B., Chowienczyk, P. J., and Shah, A. M. (2009). Neuronal nitric oxide synthase and human vascular regulation. Trends Cardiovasc. Med. 19, 256-262.
66. Ming, X. F., Montani, J. P., and Yang, Z. (2012). Perspectives of targeting mTORC1-S6K1 in cardiovascular aging. Front. Physiol. 3:5. doi:10.3389/fphys.2012.00005
67. Moens, A. L., and Kass, D. A. (2006). Tetrahydrobiopterin and cardiovascular disease. Arterioscler. Thromb. Vasc. Biol. 26, 2439-2444.
68. Moens, A. L., Vrints, C. J., Claeys, M. J., Timmermans, J. P., Champion, H. C., and Kass, D. A. (2008). Mechanisms and potential therapeutic targets for folic acid in cardiovascular disease. Am. J. Physiol. Heart Circ. Physiol. 294, H1971-H977.
69. Moncada, S., and Higgs, E. A. (2006). The discovery of nitric oxide and its role in vascular biology. Br. J. Pharmacol. 147(Suppl. 1), S193-S201.
70. Moreau, K. L., Meditz, A., Deane, K. D., and Kohrt, W. M. (2012). Tetrahydrobiopterin improves endothelial function and decreases arterial stiffness in estrogen-deficient post-menopausal women. Am. J. Physiol. Heart Circ. Physiol. 302, H1211-H1218.
71. Muller-Delp, J. M., Spier, S. A., Ramsey, M. W., and Delp, M. D. (2002). Aging impairs endothelium-dependent vasodilation in rat skeletal muscle arterioles. Am. J. Physiol. Heart Circ. Physiol. 283, H1662-H1672.
72. Mungrue, I. N., Gros, R., You, X., Pirani, A., Azad, A., Csont, T., Schulz, R., Butany, J., Stewart, D. J., and Husain, M. (2002). Cardiomyocyte overexpression of iNOS in mice results in peroxynitrite generation, heart block, and sudden death. J. Clin. Invest. 109, 735-743.
73. Nakata, S., Tsutsui, M., Shimokawa, H., Yamashita, T., Tanimoto, A., Tasaki, H., Ozumi, K., Sabanai, K., Morishita, T., Suda, O., Hirano, H., Sasaguri, Y., Nakashima, Y., and Yanagihara, N. (2007). Statin treatment upregulates vascular neuronal nitric oxide synthase through Akt/NF-kappaB pathway. Arterioscler. Thromb. Vasc. Biol. 27, 92-98.
74. Napoli, C., Aldini, G., Wallace, J. L., de Nigris, F., Maffei, R., Abete, P., Bonaduce, D., Condorelli, G., Rengo, F., Sica, V., D'Armiento, F. P., Mignogna, C., de Rosa, G., Condorelli, M., Lerman, L. O., and Ignarro, L. J. (2002). Efficacy and age-related effects of nitric oxide-releasing aspirin on experimental restenosis. Proc. Natl. Acad. Sci. U. S. A. 99, 1689-1694.
75. Nelson, H. D., Humphrey, L. L., Nygren, P., Teutsch, S. M., and Allan, J. D. (2002). Postmenopausal hormone replacement therapy: scientific review. JAMA 288, 872-881.
76. Nisoli, E., Tonello, C., Cardile, A., Cozzi, V., Bracale, R., Tedesco, L., Falcone, S., Valerio, A., Cantoni, O., Clementi, E., Moncada, S., and Carruba, M. O. (2005). Calorie restriction promotes mitochondrial biogenesis by inducing the expression of eNOS. Science 310, 314-317.
77. Novella, S., Dantas, A. P., Segarra, G., Novensa, L., Bueno, C., Heras, M., Hermenegildo, C., and Medina, P. (2010). Gathering of aging and estrogen withdrawal in vascular dysfunction of senescent accelerated mice. Exp. Gerontol. 45, 868-874.
78. Novella, S., Dantas, A. P., Segarra, G., Novensa, L., Heras, M., Hermenegildo, C., and Medina, P. (2011). Aging enhances contraction to thromboxane A(2) in aorta from female senescence-accelerated mice. Age (Dordr.). PMID: 22102320. [Epub ahead of print].
79. Novensa, L., Novella, S., Medina, P., Segarra, G., Castillo, N., Heras, M., Hermenegildo, C., and Dantas, A. P. (2011). Aging negatively affects estrogens-mediated effects on nitric oxide bioavailability by shifting ERalpha/ERbeta balance in female mice. PLoS ONE 6, e25335. doi:10.1371/journal.pone.0025335
80. Obeid, R., Kirsch, S. H., Kasoha, M., Eckert, R., and Herrmann, W. (2011). Concentrations of unmetabolized folic acid and primary folate forms in plasma after folic acid treatment in older adults. Metab. Clin. Exp. 60, 673-680.
81. Pallàs, M., Junyent, F., Verdaguer, E., Beas-Zarate, C., and Camin, A. (2010). Aging control with resveratrol. Drug Discov. Today Ther. Strateg. 7, 51-56.
82. Peluffo, G., and Radi, R. (2007). Biochemistry of protein tyrosine nitration in cardiovascular pathology. Cardiovasc. Res. 75, 291-302.
83. Presley, T. D., Morgan, A. R., Bechtold, E., Clodfelter, W., Dove, R. W., Jennings, J. M., Kraft, R. A., King, S. B., Laurienti, P. J., Rejeski, W J., Burdette, J. H., Kim-Shapiro, D. B., and Miller, G. D. (2011). Acute effect of a high nitrate diet on brain perfusion in older adults. Nitric Oxide 24, 34-42.
84. Qiao, X., McConnell, K. R., and Khalil, R. A. (2008). Sex steroids and vascular responses in hypertension and aging. Gend. Med. 5(Suppl. A), S46-S64.
85. Rajapakse, A. G., Yepuri, G., Carvas, J. M., Stein, S., Matter, C. M., Scerri, I., Ruffieux, J., Montani, J. P., Ming, X. F., and Yang, Z. (2011). Hyperactive S6K1 mediates oxidative stress and endothelial dysfunction in aging: inhibition by resveratrol. PLoS ONE 6, e 19237. doi:10.1371/journal.pone.0019237
86. Rodriguez-Manas, L., El-Assar, M., Vallejo, S., Lopez-Doriga, P., Solis, J., Petidier, R., Montes, M., Nevado, J., Castro, M., Gomez-Guerrero, C., Peiro, C., and Sanchez-Ferrer, C. E (2009). Endothelial dysfunction in aged humans is related with oxidative stress and vascular inflammation. Aging Cell 8, 226-238.
87. Sabri, M., Ai, J., Marsden, P. A., and MacDonald, R. L. (2011). Sim-vastatin recouples dysfunctional endothelial nitric oxide synthase in experimental subarachnoid hemorrhage. PLoS ONE 6, e17062. doi:10.1371/journal.pone.0017062
88. Santhanam, L., Lim, H. K., Miriel, V., Brown, T., Patel, M., Balanson, S., Ryoo, S., Anderson, M., Irani, K., Khanday, F., Di Costanzo, L., Nyhan, D., Hare, J. M., Christianson, D. W., Rivers, R., Shoukas, A., and Berkowitz, D. E. (2007). Inducible NO synthase dependent S-nitrosylation and activation of arginase1 contribute to age-related endothelial dysfunction. Circ. Res. 101, 692-702.
89. Schmitt, C. A., Heiss, E. H., and Dirsch, V. M. (2010). Effect of resveratrol on endothelial cell function: molecular mechanisms. Biofactors 36, 342-349.
90. Seals, D. R., Jablonski, K. L., and Donato, A. J. (2011). Aging and vascular endothelial function in humans. Clin. Sci. 120, 357-375.
91. Shepherd, J., Blauw, G. J., Murphy, M. B., Bollen, E. L., Buckley, B. M., Cobbe, S. M., Ford, I., Gaw, A., Hyland, M., Jukema, J. W., Kamper, A. M., Mac-Far lane, P. W., Meinders, A. E., Norrie, J., Packard, C. J., Perry, I. J., Stott, D. J., Sweeney, B. J., Twomey, C., and Westendorp, R. G. (2002). Pravastatin in elderly individuals at risk of vascular disease (PROSPER): a randomised controlled trial. Lancet 360, 1623-1630.
92. Smith, A. R., Visioli, F., Frei, B., and Hagen, T. M. (2006a). Age-related changes in endothelial nitric oxide synthase phosphorylation and nitric oxide dependent vasodilation: evidence for a novel mechanism involving sphingomyelinase and ceramide-activated phosphatase 2A. Aging Cell 5, 391-400.
93. Smith, A. R., Visioli, F., and Hagen, T. M. (2006b). Plasma membrane-associated endothelial nitric oxide synthase and activity in aging rat aortic vascular endothelia markedly decline with age. Arch. Biochem. Biophys. 454, 100-105.
94. Smith, C. J., Santhanam, L., Bruning, R. S., Stanhewicz, A., Berkowitz, D. E., and Holowatz, L. A. (2011). Upregulation of inducible nitric oxide synthase contributes to attenuated cutaneous vasodilation in essential hypertensive humans. Hypertension 58, 935-942.
95. Sobko, T., Marcus, C., Govoni, M., and Kamiya, S. (2010). Dietary nitrate in Japanese traditional foods lowers diastolic blood pressure in healthy volunteers. Nitric Oxide 22, 136-140.
96. Stice, J. P., Eiserich, J. P., and Knowlton, A. A. (2009). Role of aging versus the loss of estrogens in the reduction in vascular function in female rats. Endocrinology 150, 212-219.
97. Sun, D., Huang, A., Yan, E. H., Wu, Z., Yan, C., Kaminski, P. M., Oury, T. D., Wolin, M. S., and Kaley, G. (2004). Reduced release of nitric oxide to shear stress in mesenteric arteries of aged rats. Am. J. Physiol. Heart Circ. Physiol. 286, H2249-H2256.
98. Taddei, S., Virdis, A., Ghiadoni, L., Salvetti, G., Bernini, G., Magagna, A., and Salvetti, A. (2001). Age-related reduction of NO availability and oxidative stress in humans. Hypertension 38, 274-279.
99. Tamura, K., Yamaguchi, K., and Kogo, H. (2000). 17Beta-estradiol inhibits ovariectomy-induced expression of inducible nitric oxide synthase in rat aorta in vivo. Life Sci. 66, 259-264.
100. Tian, J., Yan, Z., Wu, Y., Zhang, S. L., Wang, K., Ma, X. R., Guo, L., Wang, J., Zuo, L., Liu, J. Y., Quan, L., and Liu, H. R. (2010). Inhibition of iNOS protects endothelial-dependent vaso dilation in aged rats. Acta Pharmacol Sin. 31, 1324-1328.
101. Timmers, S., Konings, E., Bilet, L., Houtkooper, R. H., van de Weijer, T., Goossens, G. H., Hoeks, J., van der Krieken, S., Ryu, D., Kersten, S., Moonen-Kornips, E., Hesselink, M. K., Kunz, I., Schrauwen-Hinderling, V. B., Blaak, E. E., Auwerx, J., and Schrauwen, P. (2011). Calorie restriction-like effects of 30 days of resveratrol supplementation on energy metabolism and metabolic profile in obese humans. Cell Metab. 14, 612-622.
102. Toda, N. (2011). Age-related changes in endothelial function and blood flow regulation. Pharmacol Ther. 133, 159-176.
103. Tolbert, T., Thompson, J. A., Bouchard, P., and Oparil, S. (2001). Estrogen-induced vasoprotection is independent of inducible nitric oxide synthase expression: evidence from the mouse carotid artery ligation model. Circulation 104, 2740-2745.
104. Traish, A. M., Kang, H. P., Saad, F., and Guay, A. T. (2011). Dehy-droepiandrosterone (DHEA) -a precursor steroid or an active hormone in human physiology. J. Sex. Med. 8, 2960-2983.
105. Tsutsui, M., Shimokawa, H., Otsuji, Y., Ueta, Y., Sasaguri, Y., and Yanagihara, N. (2009). Nitric oxide synthases and cardiovascular diseases: insights from genetically modified mice. Circ. J. 73, 986-993.
106. Ungvari, Z., Csiszar, A., and Kaley, G. (2004). Vascular inflammation in aging. Herz 29, 733-740.
107. Ungvari, Z., Sonntag, W. E., and Csiszar, A. (2010). Mitochondria and aging in the vascular system. J. Mol. Med. (Berl.) 88, 1021-1027.
108. Upmacis, R. K., Shen, H., Benguigui, L. E., Lamon, B. D., Deeb, R. S., Hajjar, K. A., and Hajjar, D. P. (2011). Inducible nitric oxide synthase provides protection against injury-induced thrombosis in female mice. Am. J. Physiol. Heart Circ. Physiol. 301, H617-H624.
109. van der Loo, B., Labugger, R., Skepper, J. N., Bachschmid, M., Kilo, J., Powell, J. M., Palacios-Callender, M., Erusalimsky, J. D., Quaschning, T., Malinski, T., Gygi, D., Ullrich, V., and Luscher, T. E (2000). Enhanced peroxynitrite formation is associated with vascular aging. J. Exp. Med. 192, 1731-1744.
110. Villanueva, C., and Giulivi, C. (2010). Subcellular and cellular locations of nitric oxide synthase isoforms as determinants of health and disease. Free Radic. Biol. Med. 49, 307-316.
111. Wagner, A. H., Kohler, T., Ruckschloss, U., Just, I., and Hecker, M. (2000). Improvement of nitric oxide-dependent vasodilatation by HMG-CoA reductase inhibitors through attenuation of endothelial superoxide anion formation. Arterioscler. Thromb. Vasc. Biol. 20, 61-69.
112. Wallerath, T., Deckert, G., Ternes, T., Anderson, H., Li, H., Witte, K., and Forstermann, U. (2002). Resveratrol, a polyphenolic phytoalexin present in red wine, enhances expression and activity of endothelial nitric oxide synthase. Circulation 106, 1652-1658.
113. Webb, A. J., Patel, N., Loukogeorgakis, S., Okorie, M., Aboud, Z., Misra, S., Rashid, R., Miall, P., Deanfield, J., Benjamin, N., MacAllister, R., Hobbs, A. J., and Ahluwalia, A. (2008). Acute blood pressure lowering, vasoprotective, and antiplatelet properties of dietary nitrate via bioconversion to nitrite. Hypertension 51, 784-790.
114. Wenzel, P., Daiber, A., Oelze, M., Brandt, M., Closs, E., Xu, J., Thum, T., Bauersachs, J., Ertl, G., Zou, M. H., Forstermann, U., and Munzel, T. (2008). Mechanisms underlying recoupling of eNOS by HMG-CoA reductase inhibition in a rat model of streptozotocin-induced diabetes mellitus. Atherosclerosis 198, 65-76.
115. Weverling-Rijnsburger, A. W., Blauw, G. J., and Meinders, A. E. (2004). Effect of atorvastatin on impaired vascular function in healthy old men. J. Clin. Pharm. Ther. 29, 157-164.
116. Whelan, A. P., Sutherland, W. H., McCormick, M. P., Yeoman, D. J., de Jong, S. A., and Williams, M. J. (2004). Effects of white and red wine on endothelial function in subjects with coronary artery disease. Intern. Med. J. 34, 224-228.
117. Williams, M. R., Dawood, T., Ling, S., Dai, A, Lew, R., Myles, K., Funder, J. W., Sudhir, K., and Komesaroff, P. A. (2004). Dehydroepiandrosterone increases endothelial cell proliferation in vitro and improves endothelial function in vivo by mechanisms independent of androgen and estrogen receptors. J. Clin. Endocrinol. Metab. 89, 4708-4715.
118. Wong, R. H., Howe, P. R., Buckley, J. D., Coates, A. M., Kunz, I., and Berry, N. M. (2011). Acute resveratrol supplementation improves flow-mediated dilatation in overweight/obese individuals with mildly elevated blood pressure. Nutr. Metab. Cardiovasc. Dis. 21, 851-856.
119. Wu, S., Ruan, Y., Yin, M., and Lai, W (2007). Research on the age-related changes in the nitric oxide pathway in the arteries of rats and the intervention effect of dehy-droepiandrosterone. Gerontology 53, 234-237.
120. Xia, N., Daiber, A., Habermeier, A., Closs, E. I., Thum, T., Spanier, G., Lu, Q., Oelze, M., Torzewski, M., Lackner, K. J., Munzel, T., Forstermann, U., and Li, H. (2010). Resveratrol reverses endothelial nitricoxide synthase uncoupling in apolipoprotein E knockout mice. J. Pharmacol. Exp. Ther. 335, 149-154.
121. Xing, D., Nozell, S., Chen, Y. F., Hage, F., and Oparil, S. (2009). Estrogen and mechanisms of vascular protection. Arterioscler. Thromb. Vasc. Biol. 29, 289-295.
122. Yang, B., Larson, D. F., and Watson, R. R. (2004). Modulation of iNOS activity in age-related cardiac dysfunction. Life Sci. 75, 655-667.
123. Yang, Y M., Huang, A., Kaley, G., and Sun, D. (2009). eNOS uncoupling and endothelial dysfunction in aged vessels. Am. J. Physiol. Heart Circ. Physiol. 297, H1829-H1836.
124. Yoon, H. J., Cho, S. W., Ahn, B. W., and Yang, S. Y (2010). Alterations in the activity and expression of endothelial NO synthase in aged human endothelial cells. Mech. Ageing Dev. 131, 119-123.
125. Zhang, Y., Janssens, S. P., Wingler, K., Schmidt, H. H., and Moens, A. L. (2011). Modulating endothelial nitric oxide synthase: a new cardiovascular therapeutic strategy. Am. J. Physiol. Heart Circ. Physiol. 301, H634-H646.
126. Zhang, Z., Wang, M., Xue, S. J., Liu, D. H., and Tang, Y. B. (2012). Simvastatin ameliorates angiotensin II-induced endothelial dysfunction through restoration of Rho-BH4-eNOS-NO pathway. Cardiovasc. Drugs Ther. 26, 31-40.
127. Zhou, Y H., Tang, J. Y., Wu, M. J., Lu, J., Wei, X., Qin, Y Y., Wang, C., Xu, J. F., and He, J. (2011). Effect of folic acid supplementation on cardiovascular outcomes: a systematic review and meta-analysis. PLoS ONE 6, e25142. doi:10.1371/journal.pone.0025142
128. Zhu, Y., Bian, Z., Lu, P., Karas, R. H., Bao, L., Cox, D., Hodgin, J., Shaul, P. W., Thoren, P., Smithies, O., Gustafsson, J. A., and Mendelsohn, M. E. (2002). Abnormal vascular function and hypertension in mice deficient in estrogen receptor beta. Science 295, 505-508.